Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04881682

Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University of Ulm · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a randomized controlled study evaluating safety and efficacy of repeated immunoadsorption versus immunoglobulins in steroid-refractory Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

Conditions

Interventions

TypeNameDescription
DEVICEImmunoadsorptionsee arm/group description
BIOLOGICALImmunoglobulinssee arm/group description

Timeline

Start date
2023-05-01
Primary completion
2026-03-01
Completion
2026-03-01
First posted
2021-05-11
Last updated
2024-12-05

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04881682. Inclusion in this directory is not an endorsement.

Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (NCT04881682) · Clinical Trials Directory